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ABSTRACT
Objective: Acute respiratory tract infection (ARTI) is common and has the highest death rate in children, especially in growing countries such as 
Indonesia. The aim of the research is to identify drug-related problems (DRPs) in pediatric ARTI patients based on the DRP classification by Cipolle, 
Strand, and Morley, which included categories such as unnecessary drug therapy, need additional therapy, ineffective drug, dosage adjustments such 
as too low or too high, and adverse drug reaction which is drug interaction.
Methods: The design of the study was cross-sectional and descriptive with a retrospective method. The sample of the study was the overall prescriptions 
to upper respiratory tract infection patients in Tebet Subdistrict Health Center from July to December 2018 that fulfilled all of the inclusion criteria, 
using the total sampling method. Total samples that were analyzed were from 179 sheets of prescription with a total of 498 prescriptions.
Results: The results of the research based on each parameter were inaccurate drug selection (9.5%), inaccurate indication (12.8%), mismatched dose 
(79.9%), and drug interaction (0.6%).
Conclusion: DRPs in ARTI pediatric patients resulted in a high-risk condition so that the health facilities need to improve their prescribing pattern and 
monitor and manage each therapy as well as do a routine prescription assessment to minimize the incidence of DRPs and achieve a rational drug usage.
Keywords: Acute respiratory tract infection, Drug-related problems, pediatric, Tebet subdistrict health center, Cipolle.
INTRODUCTION
Acute respiratory tract infection (ARTI) is one of many diseases caused 
by viruses or bacteria. ARTI has a high mortality potential, especially 
in children [1]. This was shown by statistical data published by the 
World Health Organization in 2018 that stated that the world’s most 
frequent cause of mortality for children <5 years old was ARTI. A survey 
conducted by the United Nations Children’s Fund in 2016 showed that 
the mortality rate for ARTI in children <5 years old had increased from 
15% in 2015 to 16% in 2016 [2]. In addition, the prevalence of ARTI in 
developing countries, such as Bangladesh, India, Indonesia, and Nepal, 
accounts for 40% of the global mortality rate due to ARTI in various age 
groups [3]. Data from the Ministry of Health in 2015 showed that ARTI 
ranked first of the 10 most prevalent diseases in Indonesia, with a total 
of 50,555 cases (39.85%).
The high prevalence of ARTI in pediatric patients results in drug 
prescription and usage [4]. Pediatric patients are at high risk of 
medication error due to pharmacokinetic mechanisms and their 
organs’ imperfect physiologic function [5]. Special attention needs to 
be taken when providing drug therapy to pediatric patients to avoid 
treatment problems and so that adverse effects or treatment failure can 
be minimized. One effort to prevent this is by analyzing drug-related 
problems (DRPs) in prescribed drugs [6].
A DRP is an unexpected event in a patient’s experience that is a result 
of or suspected to be a result of drug therapy, thereby affecting the 
expected success of healing. A DRP can be in the form of an incorrect 
dose that is either too high or too low, an unsuitable indication for the 
drug therapy, patient compliance, drug selection errors, and adverse 
reactions [7,8]. DRPs put the patient’s quality of life at high risk, increase 
patient morbidity and mortality, and increase the cost of treatment. 
This study used classification according to Cipolle, Strand, and Morley 
conducting the DRP analysis since that system tends to prioritize safety 
and successful drug therapy for patients [9].
METHODS
This research is a descriptive retrospective study. This study used 
a cross-sectional study design and used secondary data on drug 
prescription in pediatric ARTI patients in the Tebet Subdistrict Health 
Center for the period from July 2018 to December 2018. This research 
was conducted at the Tebet Subdistrict Health Center, South Jakarta, 
for 6 months from February 2019 to July 2019. Data retrieval was 
conducted over 2 months from February 2019 to March 2019. The study 
has received a research permit from Unit Pelaksana Pelayanan Terpadu 
Satu Pintu, Kota Administrasi Jakarta Selatan by number 237/082.61.
The study population was all patient prescriptions in the IMDT clinic 
of Tebet Subdistrict Health Center in the period from July 2018 to 
December 2018. Samples for this study were all prescriptions in the 
IMDT Clinic, Subdistrict Health Center during the period from July to 
December 2018 that met the inclusion criteria. Sampling was done by 
the total sampling method. The inclusion criteria of this study included 
prescriptions for pediatric ARTI patients with an ICD X code for upper 
ARTI, consisting of otitis media (H66), sinusitis (J01), pharyngitis (J02), 
tonsillitis (J03), and laryngitis-tracheitis (J04); prescriptions given 
to patients aged <6 years; and prescriptions that only had one ICD X 
diagnosis code. In addition, the exclusion criteria for this study were 
prescriptions that were incomplete and prescriptions that were not 
entered into the system so that they were unread.
In this study, DRP classification based on Cipolle et al. (2012) was 
recategorized into four major parameters, which were the accuracy of 
drug selection (consisting of unnecessary drug therapy and adjunctive 
drug therapy), accuracy of indication (ineffective drugs), dosage suitability 
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(excessive or insufficient dose), and the potential for drug interactions [7]. 
In addition, patient characteristics consisting of the patient’s age, sex, and 
body weight as well as the patient’s prescribing picture, both drug classes 
and drug preparations became the sample overview in this study.
Data analysis was performed in 2018 by univariate analysis using 
Microsoft Excel macOS. This analysis looked at the frequency 
distribution of DRPs in pediatric ARTI patients based on several 
parameters. Furthermore, the data were used to analyze the percentage 
of DRPs and the possible occurrence of interactions due to drug therapy 
using the IBM Micromedex® Web Access Application and/or Drug 
Interaction Checker Medscape application.
RESULTS
The number of prescriptions used as research samples was 179 
prescription pages. The samples were secondary data (electronic 
prescription or e-prescription) that were obtained from the database 
of Tebet Subdistrict Health Center’s information system in the SIKDA 
Optima online site. These are the characteristics of the research samples 
that were categorized based on the patients’ sex, age, and weight.
Based on Table 1, more pediatric ARTI patients were male (55.3%) than 
female (44.7%). ARTI cases most commonly happened in the age group 
of 3–6 years old (81.6%). Patients with normal body weight of 10–18 kg 
(78.2%) also experienced the highest incidence of ARTI compared to 
both the underweight and the overweight categories.
There were a total of 179 prescription sheets consisting of 498 drug 
prescriptions. Drug prescription in ARTI patients could be categorized 
into two groups, according to the active substances (drug classes) of 
each drug prescription and the drug preparation. The following are an 
overview of drug prescriptions:
Based on Table 2, the drug prescription-based category was further 
categorized into several categories: The most used drug in the category 
of analgesic-antipyretic was paracetamol (19.4%), the most used 
corticosteroid was dexamethasone (14.3%), most used supplement was 
Vitamin C (12.0%), most used antihistamine was CTM (11.8%), most 
used antibiotic was amoxicillin (9.6%), most used cough remedy was 
expectorant (8.1%), most used bronchodilator was salbutamol (2.3%), 
and the most used drug within the other category was antiemetic (0.6%).
Based on Table 3, the drug preparations prescribed in pediatric ARTI 
patients consisted of syrup (50.6%), powder (24.7%), dry syrup (13.5%), 
tablets (10.0%), suspension (0.6%), drops (0.4%), and cream (0.2%).
In this study, an event could be classified as a DRP if in one sheet of a pediatric 
ARTI patient’s prescription, there were one or more discrepancies in one 
or more parameters of the four categories. The percentage of DRP events 
in each category can be seen in the following table:
From Table 4, it can be concluded that the percentage of incorrect drug 
therapy is 9.5%, with 8.9% needing adjunctive drug therapy and 0.6% 
unnecessary drug therapy.
Based on Table 5, inaccurate indication happened in 23 patient 
prescriptions, consisting of incorrect drug prescription and ineffective 
drug for the patient.
It is shown in Table 6 that the percentage of dose unsuitability was 
79.9%, including inadequate (27.9%) and excessive (52.0%) dose.
Based on Table 7, the potential incidence of drug interactions in 
pediatric ARTI prescriptions is 0.6%, namely, one case of the interaction 
between erythromycin and dexamethasone.
DISCUSSION
Characteristics of the research samples
The characteristics of the research samples consisted of gender, patient 
age, and patient weight. There were a higher percentage of male 
patients (55.3%) than female ones (44.7%) in the ARTI patients. This 
was due to greater outdoor activities and air exposure in male toddlers, 
hence a lower immune system [10].
The incidence of ARTI was higher in preschool children (3–<6 years) at 
81.6% since toddlers have begun to actively engage in outdoor activities, 
Table 1: Characteristics of research samples based on the 
number of patients











Table 2: Overview of drug prescriptions in pediatric ARTI 
patients based on drug category








Vitamin C 95 12.0
Vitamin B complex 47 6.0
Suprabion 22 2.8
Vitamin B6 3 0.4
Antihistamine












Antiemetic: domperidone 6 0.7
Antacid 6 0.7
Acyclovir tablets 1 0.1
Nystatin drop 1 0.1
Chloramphenicol drop 1 0.1
Acyclovir cream 1 0.1
ARTI: Acute respiratory tract infection
Table 3: Prescribed drug preparation for pediatric ARTI 
patients based on the number of prescriptions
Drug preparations Number (n=498) Percentage
Syrup 252 50.6
Powder 123 24.7





ARTI: Acute respiratory tract infection
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such as playing, socializing, finding out about science, and being exposed 
to air on the highway, and some have even started education in formal 
schools and bought food carelessly, thereby increasing vulnerability to 
certain diseases, especially infectious diseases [10,11]. Within this age 
group, children also experienced their first infection when they had not 
formed optimal immunity, hence the higher incidence of ARTI [12].
Patient’s weight was also a sample characteristic in this study, with the 
highest number being 10–18 kg (78.2%). This is because the toddlers’ 
weight, which is associated with age, will affect the toddler’s nutritional 
status. The better the nutritional status of the toddler, the incidence of 
disease tends to decrease. If their nutritional status tends to be good, then 
there are other factors that might affect their health, such as pollution 
exposure, the environment, socioeconomic status, and other factors [13].
Overview of prescriptions for pediatric ARTI patients
ARTI and its accompanying symptoms will affect drug prescribing, 
which consists of antibiotics, antihistamines, analgesics, expectorants, 
and multivitamins. Analgesic-antipyretic drugs were the most 
commonly prescribed drugs for pediatric ARTI patients. This was 
shown by the usage of paracetamol, which reached the percentage of 
19.3%. Paracetamol is generally prescribed to relieve pain and/or fever 
in pediatric ARTI patients [14].
Corticosteroid drugs in the form of dexamethasone with the percentage 
of 14.3% were the second most-prescribed drug for pediatric ARTI 
patients. Anti-inflammatory drugs classified as corticosteroids aim 
to suppress the inflammatory response and immune response by 
inhibiting the formation of bradykinin and the release of neuropeptides 
from nerve endings that can cause pain since ARTI patients usually 
have pain complaints, especially in the throat or ears, that are caused 
by inflammation [15]. The administration of anti-inflammatory drugs is 
expected to relieve pain complaints in pediatric ARTI patients. However, 
the use of corticosteroids in pediatric patients is more limited since 
they inhibit the growth of children through somatostatin stimulation 
and eventually inhibit growth hormone [14].
The highest percentage of vitamin use was Vitamin C, which was equal 
to 12.0% of all drugs. This is because Vitamin C is an essential vitamin 
for humans and a cofactor for various metabolic reactions that can 
enhance the immune system. The use of Vitamin C along with iron-
containing supplements will increase absorption in the gastrointestinal 
tract, thereby improving the quality and nutritional status in pediatric 
patients [16].
The fourth most-prescribed drug for pediatric ARTI patients is 
antihistamines. Antihistamines are used as a therapy for certain allergies 
and can also be used in combination with cough medicines due to its 
sedative effect, hence its ability to suppress the itching in the throat [17].
Oral antibiotics are widely used for the treatment of ARTI, especially 
in pediatric patients. Antibiotics occupied the fifth place in the most-
prescribed drugs for pediatric ARTI patients, with a total use of 
amoxicillin as high as 9.6%. The use of antibiotics is aimed to prevent 
and overcome bacteria that cause infections in ARTI patients [14]. The 
use of amoxicillin therapy is recommended for recurrent ARTI to avoid 
resistance to cotrimoxazole [18].
Cough medicine was given to pediatric ARTI patients to reduce 
symptoms in the form of phlegm cough, both expectorant (8.1%) and 
mucolytic (6.1%). In addition, bronchodilators such as salbutamol were 
given to 2.3% to relieve symptoms related to shortness of breath and 
asthma, due to the exposure to infectious agents on the airways [19]. 
Antiemetics are prescribed to relieve nausea and vomiting in pediatric 
ARTI patients [20]. Antacids are used to treat gastritis to neutralize 
excessive stomach acid. Antacids contain weak bases of aluminum 
hydroxide or magnesium hydroxide [21]. Antivirals in the treatment of 
pediatric ARTI patients are intended for ARTI caused by viruses, such 
as influenza viruses [22].
In addition to oral drug prescriptions, pediatric ARTI patients were 
also given topical medications. The administration of topical drugs is 
aimed at local effects. Topical medications consisted of acyclovir cream, 
chloramphenicol drops, and also nystatin drops. Chloramphenicol drops 
and nystatin drops are used as antiseptics in certain parts of the infected 
organ, such as the ears and mouth [1]. As for the administration of 
acyclovir cream, it is possible that the patients experienced other diseases 
such as herpes simplex or varicella so that topical therapy was given [23].
Table 4: Percentage of accuracy of drug selection
Accuracy of drug selection Amount of patients’ prescriptions Total of R/s
Number (n=179) Percentage Number (n=498) Percentage
Accurate drug selection 162 90.5 480 96.4
Inaccurate drug selection
Needing adjunctive drug therapy 16 8.9 16 3.2
Unnecessary drug therapy 1 0.6 2 0.4
Table 5: Percentage of accurate indications
Accuracy of 
indication










156 87.2 473 95.0
Inaccurate 
indication
23 12.8 25 5.0
Table 6: Percentage of dosage suitability
Dosage 
suitability








Suitable dose 36 20.1 302 60.6
Unsuitable dose
Inadequate dose 50 27.9 54 10.8
Excessive dose 93 52.0 142 28.6
Table 7: Percentage of potential drug interactions
Potential drug 
interaction








No occurrence of 
drug interaction
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In addition to the description based on the drug categories, drug 
prescriptions were also classified based on their preparations. The 
most-prescribed drug preparation was syrup preparation. The provision 
of syrup is related to the non-optimal ability of pediatric patients to 
swallow. Thus, they require drugs that are easily swallowed. Syrup also 
has a sweet taste and additional flavors and aromas so that pediatric 
patients are interested [18,24]. Powder was also prescribed often for 
pediatric ARTI patients. This is due to the required dose adjustment for 
pediatric ARTI patients [25]. Another reason is the limited drug stock 
in the pharmacy of the public health center. Pediatric patients also do 
not yet have the optimal ability to swallow (administration route) and 
maintain compliance in consuming many drugs [24].
Identification of DRPs
Accuracy of drug selection
Adjunctive drug therapy is carried out if the patient is diagnosed with 
an illness according to the ICD X code but does not get the appropriate 
drug therapy. Additional drug therapy is common in the diagnosis of 
J03 (tonsillitis). This happens because many prescribed drugs are 
given to only reduce the symptoms of the disease without giving other 
drugs aimed at treating the infection, for example, giving paracetamol 
(analgesic-antipyretic) and ambroxol (cough medicine) alone without 
being accompanied by antibiotics or an anti-inflammatory.
Unnecessary drug therapy occurred in one prescription that had the 
ICD X diagnosis code of J03 (tonsillitis). The administration of acyclovir 
in the form of tablets and cream was considered unnecessary. Antiviral 
prescription in pediatric ARTI patients is considered unnecessary 
because acyclovir is generally prescribed for herpes patients or varicella 
infections to reduce the length of fever and the number of lesions in the 
body due to viruses [23].
Unnecessary drug therapy may also occur in some drug prescriptions 
because the drugs decrease the symptoms of the disease or improve the 
patient’s condition. Thus, overuse of some drugs such as domperidone, 
antacids, and supplements containing iron, such as Suprabion® often 
occur. Prescription of domperidone in pediatric ARTI patients aims 
to treat nausea and vomiting due to fever suffered by the patients. In 
addition, pediatric ARTI patients are given antacids to treat stomach 
pain due to increased stomach acid [26]. Supplementation is also done 
to maintain the child’s appetite and nutritional status during infection. 
However, high doses of these supplements will actually affect the 
growth of these pediatric patients. Thus, it should be used according to 
the patient’s condition [16].
Accuracy of indication
Inaccurate indication often happened with prescription of Suprabion® 
multivitamin. Suprabion multivitamin use is intended for undernourished 
patients. The supplement, however, was also prescribed for children 
with normal nutritional status according to their body weight and age. 
This prescription can potentially cause DRP since prescribing Suprabion 
multivitamin in normal and overnourished patients is ineffective and 
irrational. However, this was not supported by information about 
laboratory results that might be a parameter for supplementation. On 
the other hand, iron supplementation for pediatric patients tends to 
increase the absorption of Vitamin C in the gastrointestinal tract, which 
can improve the nutritional status of pediatric patients. Management that 
needs to be done and is a concern is the prescription of drugs in accordance 
with general guidelines for pediatric patients and the appropriate use of 
vitamins and supplements to achieve judicious use of drugs [16].
Dose suitability
Dose unsuitability consists of inadequate and excessive doses. Based on 
this research, inadequate dose mostly happened in administration of syrup 
preparation, especially in the prescription of amoxicillin and paracetamol. 
An antibiotic has to be prescribed for 7 days, unsuitable or inadequate dose 
may increase the prevalence of antibiotic resistance [27,28]. Meanwhile, 
there is no explanation for the inadequate dose of paracetamol. It is an 
over-the-counter drug so it is safer if given according to the appropriate 
dose. However, an overdose will cause hepatotoxicity [29].
Excessive dose is a higher than standard administration of drug 
doses [30]. In this case, excessive dose means that it exceeds the 
minimum toxic level, so the potential for toxic effects will be higher. In 
this study, the incidence of overdose occurred in dexamethasone drugs 
and supplements. The broad use of dexamethasone, its convenience to 
obtain, and its quick therapeutic effect cause this drug to get a lot of 
abuse, for example, in the form of incompatibility with indications or 
doses. Dexamethasone in high doses will cause damage to vital body, 
such as the liver, kidneys, and gastric mucosa. Damage to these organs 
causes decreased function and cell death (cell necrosis), thus affecting 
the body health in general [31].
Potential drug interaction
Potential drug interaction events also occurred in the dexamethasone-
erythromycin prescription. Dexamethasone belongs to the corticosteroid 
group that can reduce the expression of inflammatory genes through 
the inhibition of NF-kB induced by histone acetylation, whereas 
erythromycin is a macrolide antibiotic that is effective for diseases related 
to chronic breathing [32]. Interactions that occur include inhibition of 
erythromycin metabolism by dexamethasone. This occurs by the effect 
of dexamethasone on the intestinal enzymes in CYP3A4 metabolism. In 
addition, the combination of erythromycin-dexamethasone can increase 
the effects of the corticosteroid by reducing the inflammatory effect 
shown by inhibition of the PI3K-delta/Akt pathway. This interaction also 
causes an increase in expression of alpha GR receptors [32]. Since the 
interactions are quite serious, it is necessary to replace erythromycin 
or use an alternative medicine. Drug replacement is done by replacing 
the antibiotic with commonly given antibiotics such as amoxicillin 
or eliminating the use of anti-inflammatory drugs in patients during 
erythromycin use. In addition, health facilities should also file or collect 
data on interactions that occur as well as routine monitoring of all types 
of interactions [1,33].
CONCLUSION
DRPs in ARTI pediatric patients resulted in high-risk conditions; 
therefore, the health facilities need to improve their prescribing 
patterns and monitor and manage each therapy, and perform routine 
prescription assessment to minimize the incidence of DRPs and achieve 
rational drug usage.
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